Chemoinformaics analysis of (6R,7S)-7-METHYL-6,7-DIHYDRO-5H-CYCLOPENTA[C]PYRIDIN-6-OL
| Molecular Weight | 149.193 | nRot | 0 |
| Heavy Atom Molecular Weight | 138.105 | nRig | 10 |
| Exact Molecular Weight | 149.084 | nRing | 2 |
| Solubility: LogS | -0.338 | nHRing | 1 |
| Solubility: LogP | 0.813 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 24.2667 |
| nHD | 1 | BPOL | 12.1753 |
| QED | 0.599 |
| Synth | 3.417 |
| Natural Product Likeliness | 1.434 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.003 |
| HIA | 0.005 |
| CACO-2 | -4.226 |
| MDCK | 0.0000304 |
| BBB | 0.819 |
| PPB | 0.433996 |
| VDSS | 1.933 |
| FU | 0.618385 |
| CYP1A2-inh | 0.518 |
| CYP1A2-sub | 0.786 |
| CYP2c19-inh | 0.165 |
| CYP2c19-sub | 0.855 |
| CYP2c9-inh | 0.033 |
| CYP2c9-sub | 0.545 |
| CYP2d6-inh | 0.022 |
| CYP2d6-sub | 0.619 |
| CYP3a4-inh | 0.294 |
| CYP3a4-sub | 0.595 |
| CL | 13.706 |
| T12 | 0.514 |
| hERG | 0.038 |
| Ames | 0.03 |
| ROA | 0.717 |
| SkinSen | 0.353 |
| Carcinogencity | 0.185 |
| EI | 0.471 |
| Respiratory | 0.356 |
| NR-Aromatase | 0.538 |
| Antiviral | No |
| Prediction | 0.862642 |